GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we approach type 2 diabetes . These new medications function to mimicking the body’s own https://socialeweb.com/story7230230/glp-1-a-revolutionary-breakthrough-in-glucose-treatment